___________________________________________

WE ARE cellter

DELIVERING CELL REGENERATION THROUGH NANOPHARMACEUTICS SOLUTIONS

___________________________________________

Vision

To be the principal Biotech company in nano Pharma production. A leader in research, development, and production of disruptive nano drugs to treat pathologies of high incidence in the world.

Mission

To deliver solutions for diseases with high incidence in the world using innovative nano pharmaceutical therapies, improving significantly patients' lives.

We release the natural power of cell regeneration

We turn nano pharmaceutical drugs into triggers of natural cell regeneration. This technology is based on the natural capacity of the body to replace aged and damaged cells in the tissues. We use these properties to bio-engineer nano pharmaceutical formulations that accelerate the natural regenerative processes.  

Cellter was founded on 2016 in Santiago, Chile.

From the perspective of excellence, a multidisciplinary group of scientists and engineers with experience in physiology, stem cell technology, nanotechnology, and biotech business sought to generate solutions to the health problems that accumulate most cases of death and the highest rate of physical disabilities in the world, Cardiovascular diseases & Cancer:

 

With this purpose, Cellter was born; the first Chilean Biotech company that seeks to revolutionize the delivery of innovative nano drugs to treat pathologies of high incidence in the world.

Services


I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font. I’m a great place for you to tell a story and let your users know a little more about you.

EndOX


I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font. I’m a great place for you to tell a story and let your users know a little more about you.

The Team

Álvaro Becerra

Chief Scientific Officer

  • Grey LinkedIn Icon

Biochemist MSc., Ph.D. in Molecular Biosciences. Chief Scientific Officer and Speaker with 10 years of experience in Physiology and Pathophysiology. Member of the Chilean Society of Endocrinology & Diabetes. Passionate in unveiling the mechanism that generates vascular diseases, Alvaro has developed his career as  University professor and Researcher with publications in some of the most important journals of the field. Alvaro is committed to reinforcing the importance of vascular regeneration. 

Matías Jara

Chief Business Development Officer

  • Grey LinkedIn Icon

Biochemist MSc. Genetics. Scientist with 10 years of experience in R&D and passionate entrepreneur with 8 years of experience as Chief Business Development Officer in Biotech companies based on disruptive innovation as value generators for improving people's lives. Matías is advocated to deliver state of the art solutions that generate economic, social and environmental value.

Álvaro González

Chief Technology Officer

  • Grey LinkedIn Icon

Bioinformatics engineer, Ph.D. in Molecular Biosciences. Chief Technology Officer with 6 years of experience in Hematopoietic Stem Cells Technologies and rational drug design. Alvaro has developed his career as  Scientist and consultant for some of the most important biotech companies of U.S.A. Has developed several solutions for academic and biotech purposes, including solutions for the NIH. 

Advisors & Mentors

Some of our advisors and mentors include:

Carlos 

Leiva

Business developer, digital strategy consultant, community builder, co-founder of three companies: Andesbeat.com, Capitalizarme.com, and Reistock. Chilean Curator to StartupDigest and Chilean Ambassador for World Startup Report.

Entrepreneur and investor has made two successful sales. Co-founded in 2003 Café Origins, which he sold in 2009. In 2010 he invested in Needish.com where he co-founded clandescuento.com, which was acquired by Groupon the same year.
The year 2013 he co-founded Nazca Ventures, and in 2015 co-founded Nazca Mountain Latin America.

Felipe

Henríquez

Alejandro

Erices

Juan Manuel

Donaire

PhD., Biochemistry. Over 20 years of experience researching physiopathological mechanisms associated to Stem cells. Alejandro has developed his career as Professional, Academic and Researcher. Head of celular therapy in Clinica las Condes, Santiago, Chile. Chief of Research at VidaCel, Santiago, Chile.

MD. Oncologyst surgeon from U.Andes, MD Anderson, Instituto Nazionale per lo Studio e la Cura dei Tumori, Milan. Clinical surgeon at Clinica Las Condes, National Cancer Fundation. Director at GOCCHI, Presidential Chair of Fundation pro help of National Institute for Cancer. 

Proyects

Our Recent Projects

EndoT formulation developed by our team provides the first nano drug that leads to vascular regeneration. It is based on a bioengineered nano drug that triggers and increases mobilization of stem cells from the bone marrow to the peripheric blood. The use of our product will decrease the risks of vascular and cardiovascular diseases, improve the apheresis treatments by increasing the stem cell recovery and reducing the time necessary to achieve oncological and tissue regenerative therapies. Our fast and cost-effective R&D process performed with Node, our AI based drug discovery and development nano pharma pipeline will allow us to deliver vascular regenerative solutions for an unprecedented range of pathologies to a wide range of users.

Project supported by

Press about us

Check out the complete press portfolio about us 

Disruptive Ideas in Biotech

Cellter Alvaro Becerra (CSO) and Alvaro Gonzalez (CTO) were invited to talk about how we will use EndoT nano pharmaceutical formulation to release the natural power of cell regeneration.

Awards & Recognitions

Our Partners & Collaborators

Cellter has partnerships and collaborates with passionate and visionary teams to develop cutting-edge nanodrugs to treat high incidence diseases...

Take action

Please choose the profile that best describes you to access more information.

INVESTMENT

PARTNER

R&D SERVICES

LET´S GET IN TOUCH 

San Ignacio 1372, office #102. Santiago, Chile.

Fill out and submit the forms below for questions, ideas, and feedback. 

Copyrights©2017. cellter™
All rights reserved.
This site was designed with the
.com
website builder. Create your website today.
Start Now